Remi Mahmoud

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Patients With Inflammatory Bowel Disease

Ulcerative Colitis

Ejection Fraction

Peritoneal Dialysis

Top Venues

Alimentary pharmacology & therapeutics

Journal of Crohn's & colitis

This page only lists publications with an associated author ORCID identifier.

Publications

Remi Mahmoud, Johannes P D Schultheiss, Herma H Fidder, Bas Oldenburg
Letter: loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease-authors' reply. Alimentary pharmacology & therapeutics 55 (4) (2022)
Johannes P D Schultheiss, Remi Mahmoud, Herma H Fidder, Bas Oldenburg
Editorial: risk of loss of response to anti TNFα in patients with inflammatory bowel diseases - the longer the less? Authors' reply. Alimentary pharmacology & therapeutics 55 (2) (2022)
Johannes P D Schultheiss, Remi Mahmoud, Jonas M Louwers, Michiel T van der Kaaij, Boris P van Hellemondt, Petra G van Boeckel, Nofel Mahmmod, Bindia Jharap, Herma H Fidder, Bas Oldenburg
Loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 54 (10) (2021)
Remi Mahmoud, Chris van Lieshout, Geert W J Frederix, Bindia Jharap, Bas Oldenburg
Continuation of Anti-TNF in Patients With Ulcerative Colitis in Remission Is Not Cost-effective Compared With Treatment Withdrawal: A Markov Model. Journal of Crohn's & colitis 15 (5) (2021)
Remi Mahmoud, Steven H Itzkowitz
Editorial: missed opportunities to detect colorectal cancer in inflammatory bowel disease-getting to the root. Alimentary pharmacology & therapeutics 53 (2) (2021)